GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.

GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.

Bibliografski detalji
Glavni autori:	Hellebostad, M, Carpenter, E, Hasle, H, Mitchell, C, Vyas, P
Format:	Journal article
Jezik:	English
Izdano:	2005

Slični predmeti

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
od: Reinhardt, K, i dr.
Izdano: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
od: Reinhardt, K, i dr.
Izdano: (2010)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
od: Alford, K, i dr.
Izdano: (2011)

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
od: Gurbuxani, S, i dr.
Izdano: (2004)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
od: Garnett, C, i dr.
Izdano: (2019)

Natural history of GATA-1 mutations in Down syndrome.
od: Ahmed, M, i dr.
Izdano: (2003)

Natural history of GATA1 mutations in Down syndrome.
od: Ahmed, M, i dr.
Izdano: (2004)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
od: Hasle, H, i dr.
Izdano: (2008)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia
od: Maroz, A, i dr.
Izdano: (2014)

GATA1s induces hyperproliferation of eosinophil precursors in Down syndrome transient leukemia.
od: Maroz, A, i dr.
Izdano: (2014)

Myeloid pre-leukemia and leukemia of Down syndrome
od: Cruz Hernandez, D, i dr.
Izdano: (2020)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
od: Heald, B, i dr.
Izdano: (2007)

Down syndrome preleukemia and leukemia.
od: Maloney, K, i dr.
Izdano: (2014)

Acute leukemias in children with Down syndrome.
od: Zwaan, C, i dr.
Izdano: (2010)

Acute leukemias in children with Down syndrome.
od: Zwaan, M, i dr.
Izdano: (2008)

JAK mutations in Down syndrome - associated transient myeloproliferative disorder and acute megakaryocytic leukemia
od: Vyas, P, i dr.
Izdano: (2008)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
od: Norton, A, i dr.
Izdano: (2007)

Molecular insights into Down syndrome-associated leukemia.
od: Vyas, P, i dr.
Izdano: (2007)

Myelodysplastic syndrome due to somatic GATA1 mutation.
od: Freson, K, i dr.
Izdano: (2004)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
od: Tunstall-Pedoe, O, i dr.
Izdano: (2008)

Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
od: Daser, A, i dr.
Izdano: (2004)

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.
od: Roberts, I, i dr.
Izdano: (2013)

A Myelodysplastic Syndrome Associated with a Clonal GATA1 Mutation.
od: Freson, K, i dr.
Izdano: (2008)

Characterization of distinct GATA-1 complexes in erythroid cells.
od: Rodriguez, P, i dr.
Izdano: (2005)

GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.
od: Carpenter, E, i dr.
Izdano: (2005)

Acute megakaryoblastic leukaemia in Down syndrome and non-Down syndrome patients - molecular signature of a disease - subtypes with distinct treatment outcomes
od: Vyas, P, i dr.
Izdano: (2007)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
od: Halsey, C, i dr.
Izdano: (2006)

GATA1 mutational analysis in chronic myeloid leukaemia.
od: Halsey, C, i dr.
Izdano: (2007)

Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndrome
od: Cruz Hernandez, D, i dr.
Izdano: (2020)

Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.
od: Nesbit, M, i dr.
Izdano: (2004)

Haematology of Down syndrome.
od: Webb, D, i dr.
Izdano: (2007)

Modelling the progression of a preleukemic stage to overt leukemia in children with down syndrome
od: Labuhn, M, i dr.
Izdano: (2018)

GATA-1 forms distinct activating and repressive complexes in erythroid cells
od: Strouboulis, J, i dr.
Izdano: (2004)

GATA-1 forms distinct activating and repressive complexes in erythroid cells.
od: Rodriguez, P, i dr.
Izdano: (2005)

Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
od: Labuhn, M, i dr.
Izdano: (2019)

Influential role of cell - ECM interactions in leukemogenesis
od: Vu Thi Thu Thao
Izdano: (2012)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis.
od: Ballabio, E, i dr.
Izdano: (2012)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.
od: Buitenkamp, T, i dr.
Izdano: (2013)

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
od: Buitenkamp, T, i dr.
Izdano: (2013)

Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
od: Bourquin, J, i dr.
Izdano: (2006)